However, another research showed that in both Hep3B human hepatoma cells and primary mouse hepatocytes, the apelin/APLNR signaling pathway prevents lipid accumulation and combats hepatic steatosis by activating AMPK and inducing PPARα 39. Here, APLN is linked to fatty liver disease.